Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,9228 USD | +1,13% | -9,53% | -33,13% |
26/04 | Bluebird bio krijgt bericht van Nasdaq wegens te late indiening van jaarverslag | MT |
27/03 | BLUEBIRD BIO, INC. : Wells Fargo Securities herhaalt Neutraal advies | ZM |
Vakgebied
Aantal werknemers: 323
Verkoop per activiteit
USD in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Gene Therapies
76,1
%
| 3 | 77,8 % | 3 | 76,1 % | -3,89% |
Other
23,9
%
| 1 | 22,2 % | 1 | 23,9 % | +5,67% |
Verkoop per regio
USD in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 4 | 100,0 % | 4 | 100,0 % | -1,77% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Andrew Obenshain
CEO | Chief Executive Officer | 51 | 01-01-16 |
Director of Finance/CFO | 51 | 07-11-22 | |
Melissa Bonner
CTO | Chief Tech/Sci/R&D Officer | - | 01-12-21 |
Richard Colvin
CTO | Chief Tech/Sci/R&D Officer | 58 | 01-01-18 |
Thomas Klima
COO | Chief Operating Officer | 52 | 10-05-21 |
Nick Leschly
BRD | Director/Board Member | 51 | 01-03-10 |
Courtney OLeary
IRC | Investor Relations Contact | - | - |
Andrea Walton
HRO | Human Resources Officer | - | 01-01-22 |
Corporate Officer/Principal | 51 | 01-09-11 | |
Joseph Vittiglio
LAW | General Counsel | 52 | 03-01-23 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Mark Vachon
CHM | Chairman | 65 | 16-07-14 |
Nick Leschly
BRD | Director/Board Member | 51 | 01-03-10 |
Richard Paulson
BRD | Director/Board Member | 56 | 03-04-23 |
John Agwunobi
BRD | Director/Board Member | 59 | 08-06-17 |
Director/Board Member | 47 | 15-10-21 | |
Andrew Obenshain
CEO | Chief Executive Officer | 51 | 01-01-16 |
Najoh Tita
BRD | Director/Board Member | - | 29-09-21 |
Director/Board Member | - | 07-03-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 190 355 471 | 189 636 689 ( 99,62 %) | 0 | 99,62 % |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-33,13% | 178 mln. | |
-2,31% | 103 mld. | |
+0,56% | 95,28 mld. | |
+1,69% | 22,15 mld. | |
-17,37% | 21,02 mld. | |
-9,30% | 18,15 mld. | |
-41,01% | 16,74 mld. | |
-14,85% | 16,05 mld. | |
+3,21% | 13,68 mld. | |
+33,54% | 12,17 mld. |
- Beurs
- Aandelen
- Koers BLUE
- Onderneming bluebird bio, Inc.